Skip to main content
Caplight Logo









Cyclana Bio

Cyclana Bio

Private
CambridgeHealthcare & Life Scienceshttps://www.cyclanabio.com/

Last Round

pre_seed

Oct 20, 2025

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Cyclana Bio is a biotechnology company that develops a therapeutic discovery platform using whole-tissue models and AI-driven data integration to identify treatments for endometriosis and other chronic inflammatory diseases.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Healthcare Analytics, Precision Medicine

Business Model

B2B

Customer Profile

Services & Consulting

AI Layer

Application

Keywords

endometriosis treatmentdrug discoverywomen's healthfemtechtissue modelsin vitro researchextracellular matrixcomputational biologybiomarker analysisdrug target identificationprecision medicinehydrogel screeningbiotech startuptherapeutic pipeline

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Cyclana Bio Comparables

Compare Cyclana Bio with similar companies based on industry and business-model similarity.

Cyclana Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Metri Bio
90%
GynQura Therapeutics
87%
EndoGene.Bio
79%

Cyclana Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
pre_seedOct 20, 2025

Key People

Founding team and executive leadership

Léa Wenger

Chief Executive Officer and Founder

Founding Team

Jonathan Griffiths

Chief Technology Officer

Executive Team

Cyclana Bio Investors

Notable investors and investment history

Cyclana Bio investors
InvestorRounds
NFXpre_seed
Cocoa Venturespre_seed
Eka Venturespre_seed
Wilbe Capitalpre_seed

Market signals

Structured signals derived from secondary market and firmographic data.

  • Aug 15, 2026

    Grew 40% QoQ, from 10 to 14 employees.

  • Apr 22, 2026

    Grew 43% QoQ, from 7 to 10 employees.

Cyclana Bio Filings

Explore SEC and related filing metadata, where available.

Cyclana Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Cyclana Bio's valuation, stock price, and market status.

Is Cyclana Bio a public or private company?

Cyclana Bio is a private company.

What is the current stock price of Cyclana Bio?

Cyclana Bio is a private company with no public stock price. No recent secondary market data is available.

How much is Cyclana Bio worth (valuation)?

Valuation information for Cyclana Bio is not publicly available.

Can I buy Cyclana Bio stock?

Cyclana Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Cyclana Bio's last funding round?

Cyclana Bio's most recent funding round was Pre Seed on October 20, 2025.

Who are the main investors in Cyclana Bio?

Key investors in Cyclana Bio include NFX, Eka Ventures.

Will Cyclana Bio IPO soon?

No public IPO plans have been announced for Cyclana Bio.

How can I track Cyclana Bio secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cyclana Bio's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersCambridge
Employee Range11
Year Founded2024
Last FundingOct 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?